Table 1 Baseline social-economic and clinical characteristics (n = 121)
Characteristics | n (%) or mean ± SD | P | |
|---|---|---|---|
GST (n = 59) | Non-GST (n = 62) | ||
Age | 57.2 ± 11 | 58.5 ± 10.4 | 0.29 |
BMI | 23.4 ± 2.8 | 23.7 ± 3.04 | 0.53 |
Male | 39 (66.1%) | 45 (72.6%) | 0.44 |
Operation method | |||
TLS | 50 (84.7%) | 26 (41.9%) | <0.0001 |
LAS | 9 (15.3%) | 36 (58.1%) | |
Reconstruction | |||
Billroth1 | 0 | 1 (1.6%) | |
Billroth2 +Braun | 45 (76.3%) | 47 (75.8%) | 0.62 |
Roux-en-Y | 14 (23.7%) | 14 (22.6%) | |
Pathological Stage | |||
Stage IA | 28 (47.5%) | 17 (27.4%) | |
Stage IB | 7 (11.9%) | 8 (12.9%) | |
Stage IIA | 5 (8.5%) | 4 (6.5%) | |
Stage IIB | 6 (10.2%) | 14 (22.6%) | 0.25 |
Stage IIIA | 10 (16.9%) | 12 (19.4%) | |
Stage IIIB | 2 (3.4%) | 4 (6.5%) | |
Stage IIIC | 1 (1.7%) | 3 (4.8%) | |
Drinking History Yes | 25 (42.4%) | 30 (48.4%) | 0.51 |
Previous operation (s) | |||
Yes | 21 (35.6%) | 24 (38.7%) | 0.72 |
Comorbidities | |||
Subgroup | n = 23 | n = 33 | |
Diabetes | 8 (25%) | 7 (14.6%) | |
Hypertension | 13 (40.6%) | 21 (43.8%) | 0.45 |
Anemia | 0 | 1 (2.1%) | |
Cancer | 1 (3.1%) | 0 | |
Others | 10 (31.3%) | 19 (39.6%) | |
Reimbursement | |||
Provincial health care | 30 (50.8%) | 22 (35.5%) | |
Urban health care | 22 (37.3%) | 24 (38.7%) | 0.092 |
Self-pay | 7 (11.9%) | 16 (25.8%) | |
Surgeons | |||
Surgeon1 | 29 (49.2%) | 55 (88.7%) | |
Surgeon2 | 4 (6.8%) | 0 | |
Surgeon3 | 11 (18.6%) | 3 (4.8%) | <0.0001 |
Surgeon4 | 13 (22.0%) | 4 (6.5%) | |
Surgeon5 | 2 (3.4%) | 0 | |